Bioteque (4107) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioteque (4107) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$205.60 Million ≈ $6.48 Million USD) by net assets (NT$3.61 Billion ≈ $113.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4107 net asset quality index to measure how much of total assets are equity-financed.
Bioteque - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Bioteque's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Bioteque's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Bioteque Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioteque ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Servicios Corporativos Javer
MX:JAVER
|
0.075x |
|
G.M.I Technology Inc
TW:3312
|
0.000x |
|
Baoding Dongli Machinery Co.Ltd.
SHE:301298
|
N/A |
|
Eisen- und Hüttenwerke AG
F:EIS
|
-0.005x |
|
Armada Acquisition Corp. II
NASDAQ:XRPN
|
-0.001x |
|
Rithm Acquisition Corp.
NYSE:RAC
|
-0.001x |
|
Jiangxi Haiyuan Composites Technology Co Ltd
SHE:002529
|
0.405x |
|
MFS Charter Income Trust
NYSE:MCR
|
0.017x |
Annual Cash Flow Conversion Efficiency for Bioteque (2006–2025)
The table below shows the annual cash flow conversion efficiency of Bioteque from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Bioteque.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$3.61 Billion ≈ $113.65 Million |
NT$664.20 Million ≈ $20.93 Million |
0.184x | -9.82% |
| 2024-12-31 | NT$3.44 Billion ≈ $108.41 Million |
NT$702.62 Million ≈ $22.14 Million |
0.204x | -2.69% |
| 2023-12-31 | NT$3.19 Billion ≈ $100.51 Million |
NT$669.40 Million ≈ $21.09 Million |
0.210x | -1.30% |
| 2022-12-31 | NT$3.03 Billion ≈ $95.52 Million |
NT$644.58 Million ≈ $20.31 Million |
0.213x | +27.00% |
| 2021-12-31 | NT$2.80 Billion ≈ $88.32 Million |
NT$469.25 Million ≈ $14.78 Million |
0.167x | -29.71% |
| 2020-12-31 | NT$2.66 Billion ≈ $83.94 Million |
NT$634.51 Million ≈ $19.99 Million |
0.238x | -4.95% |
| 2019-12-31 | NT$2.49 Billion ≈ $78.39 Million |
NT$623.41 Million ≈ $19.64 Million |
0.251x | +25.93% |
| 2018-12-31 | NT$2.31 Billion ≈ $72.90 Million |
NT$460.41 Million ≈ $14.51 Million |
0.199x | +26.34% |
| 2017-12-31 | NT$2.14 Billion ≈ $67.32 Million |
NT$336.51 Million ≈ $10.60 Million |
0.157x | -14.05% |
| 2016-12-31 | NT$2.08 Billion ≈ $65.45 Million |
NT$380.63 Million ≈ $11.99 Million |
0.183x | -9.79% |
| 2015-12-31 | NT$1.90 Billion ≈ $59.79 Million |
NT$385.43 Million ≈ $12.14 Million |
0.203x | +3.65% |
| 2014-12-31 | NT$1.88 Billion ≈ $59.28 Million |
NT$368.71 Million ≈ $11.62 Million |
0.196x | +17.08% |
| 2013-12-31 | NT$1.62 Billion ≈ $50.91 Million |
NT$270.44 Million ≈ $8.52 Million |
0.167x | +17.11% |
| 2012-12-31 | NT$1.28 Billion ≈ $40.44 Million |
NT$183.44 Million ≈ $5.78 Million |
0.143x | +19.48% |
| 2011-12-31 | NT$1.24 Billion ≈ $39.10 Million |
NT$148.43 Million ≈ $4.68 Million |
0.120x | -19.79% |
| 2010-12-31 | NT$1.24 Billion ≈ $39.17 Million |
NT$185.39 Million ≈ $5.84 Million |
0.149x | +7.17% |
| 2009-12-31 | NT$1.25 Billion ≈ $39.47 Million |
NT$174.32 Million ≈ $5.49 Million |
0.139x | -40.46% |
| 2008-12-31 | NT$1.19 Billion ≈ $37.37 Million |
NT$277.23 Million ≈ $8.73 Million |
0.234x | +71.56% |
| 2007-12-31 | NT$1.17 Billion ≈ $36.95 Million |
NT$159.77 Million ≈ $5.03 Million |
0.136x | +36.92% |
| 2006-12-31 | NT$778.61 Million ≈ $24.53 Million |
NT$77.47 Million ≈ $2.44 Million |
0.099x | -- |
About Bioteque
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter… Read more